Juan (Wendy) Zhao, PhD

Research Assistant Professor

Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach

Journal article

Jacy T. Zanussi, Juan Zhao, Chad A. Dorn, Ge Liu, QiPing Feng, WeiQi Wei, Jonathan D. Mosley, C. Michael Stein, Vivian K. Kawai
Clinical Pharmacology and Therapeutics, vol. 111, 2022 Feb, pp. 435--443
Cite

Cite

APA
Zanussi, J. T., Zhao, J., Dorn, C. A., Liu, G., Feng, Q. P., Wei, W. Q., … Kawai, V. K. (2022). Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach. Clinical Pharmacology and Therapeutics, 111, 435–443.

Chicago/Turabian
Zanussi, Jacy T., Juan Zhao, Chad A. Dorn, Ge Liu, QiPing Feng, WeiQi Wei, Jonathan D. Mosley, C. Michael Stein, and Vivian K. Kawai. “Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach.” Clinical Pharmacology and Therapeutics 111 (February 2022): 435–443.

MLA
Zanussi, Jacy T., et al. “Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach.” Clinical Pharmacology and Therapeutics, vol. 111, Feb. 2022, pp. 435–43.

Share